142 related articles for article (PubMed ID: 12100798)
41. [Uterine fibroids].
Poulsen BB; Munk T; Rudnicki M; Ravn P
Ugeskr Laeger; 2017 Oct; 179(43):. PubMed ID: 29076451
[TBL] [Abstract][Full Text] [Related]
42. [Myoma: uterus can be saved with new therapeutic methods].
Nisell H; Lindblom B
Lakartidningen; 1992 Jul; 89(30-31):2514-6. PubMed ID: 1507982
[No Abstract] [Full Text] [Related]
43. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
44. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
[TBL] [Abstract][Full Text] [Related]
45. Rationale for the short-term use of luteinising hormone-releasing hormone analogues in the treatment of uterine myomata.
Stovall TG
Horm Res; 1989; 32 Suppl 1():134-6. PubMed ID: 2693324
[TBL] [Abstract][Full Text] [Related]
46. The current place of medical therapy in uterine fibroid management.
Donnez J; Donnez O; Dolmans MM
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():57-65. PubMed ID: 29169896
[TBL] [Abstract][Full Text] [Related]
47. Deep venous thrombosis associated with large leiomyomata uteri. A case report.
Stanko CM; Severson MA; Molpus KL
J Reprod Med; 2001 Apr; 46(4):405-7. PubMed ID: 11354847
[TBL] [Abstract][Full Text] [Related]
48. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
49. Uterine fibroids: clinical manifestations and contemporary management.
Doherty L; Mutlu L; Sinclair D; Taylor H
Reprod Sci; 2014 Sep; 21(9):1067-92. PubMed ID: 24819877
[TBL] [Abstract][Full Text] [Related]
50. [Uterine fibroids--therapy from the point of view of the gynaecologist].
Middendorf K; Burges A; Strauss A; Hepp H
Radiologe; 2003 Aug; 43(8):615-23. PubMed ID: 14504761
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
52. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
[TBL] [Abstract][Full Text] [Related]
53. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
Lumsden MA; West CP; Thomas E; Coutts J; Hillier H; Thomas N; Baird DT
Br J Obstet Gynaecol; 1994 May; 101(5):438-42. PubMed ID: 8018618
[TBL] [Abstract][Full Text] [Related]
54. Management of fibroids should be tailored to the patient.
King R; Overton C
Practitioner; 2011 Mar; 255(1738):19-23, 2-3. PubMed ID: 21510505
[TBL] [Abstract][Full Text] [Related]
55. Incidence and risk factors for surgical intervention after uterine artery embolization.
Park AJ; Bohrer JC; Bradley LD; Diwadkar GB; Moon E; Newman JS; Jelovsek JE
Am J Obstet Gynecol; 2008 Dec; 199(6):671.e1-6. PubMed ID: 18986639
[TBL] [Abstract][Full Text] [Related]
56. Uterine leiomyomata--a feature of acromegaly.
Cohen O; Schindel B; Homburg R
Hum Reprod; 1998 Jul; 13(7):1945-6. PubMed ID: 9740454
[TBL] [Abstract][Full Text] [Related]
57. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
Zurawin RK; Fischer JH; Amir L
J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
[TBL] [Abstract][Full Text] [Related]
58. Endoscopic management of leiomyomata.
Advincula AP; Song A
Semin Reprod Med; 2004 May; 22(2):149-55. PubMed ID: 15164310
[TBL] [Abstract][Full Text] [Related]
59. Treatment of uterine fibroid with triptorelin before hysterectomy.
Loong EP; Lo KW
Chin Med J (Engl); 1998 Jan; 111(1):67-70. PubMed ID: 10322658
[TBL] [Abstract][Full Text] [Related]
60. [Role of embolization in the management of uterine fibroids].
Kahn V; Fohlen A; Pelage JP
J Gynecol Obstet Biol Reprod (Paris); 2011 Dec; 40(8):918-27. PubMed ID: 22093440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
